Hemab Therapeutics Announces that the First Participant Has Accepted the First Phase of Clinical Trials for Hmb-003
2026-09-17 20:01:21
According to CoinMeta, as reported by Reuters, Hemab Therapeutics announced that the first participant has enrolled in the first phase of clinical trials for Hmb-003, a therapy designed to manage severe menstrual bleeding.
Source:Internet
This content is for market information only and does not constitute investment advice.
Follow HQYC official accounts to stay updated

Hot Articles
Refresh

Zcash Jumps 23% After Fed Hike, Beats Bitcoin: How Far Can It Go?
3h ago

Which Crypto Wallet Is Best? 2026 Ranking & Review
09-16 18:34

What Is CASHCAT Coin? Why It Leads On-Chain Despite 26% Weekly Drop
09-15 16:04

Top 10 Crypto Trading Apps Sept 2026: Ranking & Review
09-14 17:24

Bitcoin Trading Platforms 2026: Top 3 Exchanges Compared
09-11 18:09



